FOLIC ACID (folic acid) by Fresenius Kabi is clinical pharmacology: in man, an exogenous source of folate is required for nucleoprotein synthesis and maintenance of normal erythropoiesis. First approved in 1986.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY: In man, an exogenous source of folate is required for nucleoprotein synthesis and maintenance of normal erythropoiesis. Folic acid, whether given by mouth or parenterally, stimulates specifically the production of red blood cells, white blood cells and platelets in persons…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Folic Acid Supplementation in Calcific Aortic Valve Disease
Serum Folic Acid Status, Genotyping MTHFR 677C-->T, Plasma Homocysteine, DNA Methylation of IGF2 Gene and Microbiota of the Children: Mother-Children Cohort Study
Folic Acid and Zinc Supplementation Trial (FAZST)
Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel
Folic Acid and Vitamin B12 in Young Indian Children
Worked on FOLIC ACID at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo